A detailed history of Met Life Investment Management, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 18,524 shares of TMDX stock, worth $1.49 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,524
Previous 18,524 -0.0%
Holding current value
$1.49 Million
Previous $2.79 Million 4.23%
% of portfolio
0.02%
Previous 0.02%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$72.62 - $150.62 $143,497 - $297,625
1,976 Added 11.94%
18,524 $2.79 Million
Q1 2024

May 14, 2024

BUY
$70.86 - $89.93 $1.17 Million - $1.49 Million
16,548 New
16,548 $1.22 Million
Q3 2023

May 09, 2024

BUY
$53.47 - $96.07 $19,142 - $34,393
358 Added 2.21%
16,548 $906,000
Q2 2023

Apr 29, 2024

BUY
$66.23 - $88.73 $1.1 Million - $1.47 Million
16,548 New
16,548 $1.39 Million
Q2 2023

Aug 10, 2023

BUY
$66.23 - $88.73 $1.1 Million - $1.47 Million
16,548 New
16,548 $1.39 Million
Q1 2023

May 09, 2024

BUY
$53.63 - $82.33 $868,269 - $1.33 Million
16,190 New
16,190 $1.23 Billion
Q4 2022

Jun 14, 2023

BUY
$39.08 - $64.29 $632,705 - $1.04 Million
16,190 New
16,190 $999,000
Q3 2022

May 10, 2024

BUY
$31.56 - $55.75 $62,078 - $109,660
1,967 Added 13.83%
16,190 $675,000
Q3 2022

Jun 14, 2023

BUY
$31.56 - $55.75 $510,956 - $902,592
16,190 New
16,190 $675,000
Q3 2022

Mar 22, 2023

BUY
$31.56 - $55.75 $62,078 - $109,660
1,967 Added 13.83%
16,190 $675,000
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $62,078 - $109,660
1,967 Added 13.83%
16,190 $676,000
Q2 2022

May 10, 2024

SELL
$20.56 - $32.15 $27,509 - $43,016
-1,338 Reduced 8.6%
14,223 $447,000
Q2 2022

Jun 20, 2023

BUY
$20.56 - $32.15 $292,424 - $457,269
14,223 New
14,223 $447,000
Q2 2022

Mar 22, 2023

SELL
$20.56 - $32.15 $27,509 - $43,016
-1,338 Reduced 8.6%
14,223 $447,000
Q2 2022

Aug 11, 2022

SELL
$20.56 - $32.15 $27,509 - $43,016
-1,338 Reduced 8.6%
14,223 $447,000
Q1 2022

May 10, 2024

BUY
$12.58 - $26.94 $195,757 - $419,213
15,561 New
15,561 $419,000
Q1 2022

Jun 20, 2023

BUY
$12.58 - $26.94 $195,757 - $419,213
15,561 New
15,561 $419,000
Q1 2022

Mar 22, 2023

BUY
$12.58 - $26.94 $79,342 - $169,910
6,307 Added 68.15%
15,561 $419,000
Q1 2022

May 12, 2022

BUY
$12.58 - $26.94 $79,342 - $169,910
6,307 Added 68.15%
15,561 $419,000
Q4 2021

Jun 21, 2023

BUY
$19.16 - $32.68 $177,306 - $302,420
9,254 New
9,254 $177,000
Q3 2021

May 17, 2024

SELL
$25.92 - $34.51 $76,852 - $102,322
-2,965 Reduced 24.27%
9,254 $306,000
Q3 2021

Jun 21, 2023

BUY
$25.92 - $34.51 $239,863 - $319,355
9,254 New
9,254 $306,000
Q3 2021

Mar 22, 2023

SELL
$25.92 - $34.51 $76,852 - $102,322
-2,965 Reduced 24.27%
9,254 $306,000
Q3 2021

Nov 15, 2021

SELL
$25.92 - $34.51 $76,852 - $102,322
-2,965 Reduced 24.27%
9,254 $306,000
Q1 2021

May 17, 2024

SELL
$17.75 - $47.82 $76,839 - $207,012
-4,329 Reduced 26.16%
12,219 $506,000
Q1 2021

Jun 26, 2023

BUY
$17.75 - $47.82 $216,887 - $584,312
12,219 New
12,219 $507 Million
Q4 2020

Jun 22, 2023

BUY
$11.91 - $19.9 $145,528 - $243,158
12,219 New
12,219 $243,000
Q3 2020

Jun 26, 2023

BUY
$13.78 - $18.84 $168,377 - $230,205
12,219 New
12,219 $168,000
Q2 2020

May 24, 2024

SELL
$11.66 - $18.26 $50,476 - $79,047
-4,329 Reduced 26.16%
12,219 $219 Million
Q2 2020

Jun 26, 2023

BUY
$11.66 - $18.26 $142,473 - $223,118
12,219 New
12,219 $218,000
Q2 2020

Mar 22, 2023

BUY
$11.66 - $18.26 $56,457 - $88,414
4,842 Added 65.64%
12,219 $218,000
Q2 2020

Aug 14, 2020

BUY
$11.66 - $18.26 $56,457 - $88,414
4,842 Added 65.64%
12,219 $219,000
Q1 2020

Jul 12, 2023

BUY
$10.5 - $20.2 $77,458 - $149,015
7,377 New
7,377 $89,000
Q4 2019

Jul 12, 2023

BUY
$16.61 - $21.64 $122,531 - $159,638
7,377 New
7,377 $140,000
Q4 2019

Mar 22, 2023

SELL
$16.61 - $21.64 $146,383 - $190,713
-8,813 Reduced 54.43%
7,377 $140,000
Q4 2019

Feb 14, 2020

BUY
$16.61 - $21.64 $122,531 - $159,638
7,377 New
7,377 $140,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.57B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.